AN2 Therapeutics logo

AN2 Therapeutics

Developing therapies for rare, chronic, and serious infectious diseases

35 employees · est. 2019 · Menlo Park, United States

VS
Star Therapeutics logo

Star Therapeutics

In a universe of possibilities, we see things differently.

50 employees · est. 2018 · South San Francisco, United...

Star Therapeutics is the older company (2019 vs 2018).

Side-by-Side Comparison

AN2 Therapeutics Star Therapeutics
Founded
2019 2018 older
Headquarters
Menlo Park, United States South San Francisco, United States
Employees
35 50
Industry
Biotechnology, Health Care, Pharmaceutical Health Care, Health and Wellness
Funding Stage
Grant Series C
Total Funding
$162.00M $190.00M
Funding Rounds
4 2
Services
Drug Discovery and Development, Clinical Trials, Research and Innovation in Boron Chemistry, Therapeutic Development for Infectious Diseases and Oncology Discovery and development of antibody therapies, Patient-focused solutions
Target Customers
Healthcare Providers, Medical Research Institutions, Pharmaceutical Companies, Patients with Infectious Diseases, Oncology Patients Patients with serious diseases
Taxonomy
Biopharmaceutical, Infectious Diseases, Drug Research, Boron Chemistry, Rare Diseases, Chronic Diseases, Global Health, Drug Development, Transformational Medicines, Biomedical Expertise, Medical Innovation, California-based Company, Industry Leaders Rare Diseases, Therapeutics, Novel Biology, Antibody Therapeutics, Immunological Diseases, Cancer, Signal Regulatory Proteins, Drug Development, Precision Medicine, Life-changing Therapies
Website
an2therapeutics.com star-therapeutics.com
AN2 Therapeutics logo

About AN2 Therapeutics

AN2 Therapeutics, founded in 2019, is a promising biopharmaceutical startup headquartered in the United States. The company is spearheading efforts in the biotechnology and healthcare sectors with its noteworthy focus on developing therapies for rare, chronic, and serious infectious diseases. The c...

Star Therapeutics logo

About Star Therapeutics

Star Therapeutics, founded in 2018, is a clinical stage biotechnology company based in the United States. With a distinct vision encapsulated in its slogan, "In a universe of possibilities, we see things differently," the company is focused on discovering and developing best-in-class antibodies to c...

We will tell you when either one moves

BounceWatch watches AN2 Therapeutics and Star Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AN2 Therapeutics and Star Therapeutics — by email.

Frequently Asked Questions

AN2 Therapeutics — Developing therapies for rare, chronic, and serious infectious diseases. Star Therapeutics — In a universe of possibilities, we see things differently. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AN2 Therapeutics has raised $162.00M while Star Therapeutics has raised $190.00M.
AN2 Therapeutics and Star Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AN2 Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AN2 Therapeutics on 11 Sep 2024, and Star Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes